![Martin John Shott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin John Shott
Presidente presso European Pharmaceuticals Group Ltd.
Posizioni attive di Martin John Shott
Società | Posizione | Inizio | Fine |
---|---|---|---|
European Pharmaceuticals Group Ltd.
![]() European Pharmaceuticals Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., European Pharmaceuticals Group Ltd. is a holding British company with investments in subsidiary undertakings engaged in pharmaceuticals. The company is based in Romford, UK. European Pharmaceuticals Group was acquired by The Intercare Group Plc from Groenwondt Beheer Bv on September 17, 1999 for $40.03 million. | Presidente | 15/09/2010 | - |
Royal Pharmaceutical Society of Great Britain
![]() Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | 15/09/2010 | - |
Storia della carriera di Martin John Shott
Precedenti posizioni note di Martin John Shott
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lers-Synthelabo | Corporate Officer/Principal | - | - |
Innovata Biomed Ltd.
![]() Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Innovata Biomed Ltd. engages in the research, development, and commercialization of respiratory drug delivery technologies. The company is based in Edinburgh, UK. | Direttore Tecnico/Scientifico/R&S | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
VECTURA GROUP | Direttore operativo | 07/09/2009 | 25/11/2011 |
Corporate Officer/Principal | 25/11/2011 | - |
Formazione di Martin John Shott
The University of Nottingham | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 6 |
Svizzera | 2 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVARTIS AG | Health Technology |
Aziende private | 5 |
---|---|
Vectura Group Ltd.
![]() Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Innovata Biomed Ltd.
![]() Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Innovata Biomed Ltd. engages in the research, development, and commercialization of respiratory drug delivery technologies. The company is based in Edinburgh, UK. | Commercial Services |
European Pharmaceuticals Group Ltd.
![]() European Pharmaceuticals Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., European Pharmaceuticals Group Ltd. is a holding British company with investments in subsidiary undertakings engaged in pharmaceuticals. The company is based in Romford, UK. European Pharmaceuticals Group was acquired by The Intercare Group Plc from Groenwondt Beheer Bv on September 17, 1999 for $40.03 million. | Health Technology |
Royal Pharmaceutical Society of Great Britain
![]() Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
Lers-Synthelabo |
- Borsa valori
- Insiders
- Martin John Shott
- Esperienza